Racial differences in bone mineral density and fractures in men receiving androgen deprivation therapy for prostate cancer

Journal of Urology

Volumn 187, Issue 3, 2012, Pages 889-893

  Morgans, Alicia K ^a   Hancock, Michael L ^b   Barnette, K Gary ^b   Steiner, Mitchell S ^b   Morton, Ronald A ^b   Smith, Matthew R ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b GTx Inc   (United States)

Author keywords

androgens; bone; bone density; fractures; prostatic neoplasms; survival rate

Indexed keywords

AFRICAN AMERICAN; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; BONE DENSITY; BONE TURNOVER; CAUCASIAN; FRACTURE; HIP; HUMAN; INCIDENCE; LUMBAR SPINE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RACE DIFFERENCE; RANDOMIZED CONTROLLED TRIAL (TOPIC); VERTEBRA FRACTURE;

ABSORPTIOMETRY, PHOTON; AFRICAN CONTINENTAL ANCESTRY GROUP; AGED; ANDROGEN ANTAGONISTS; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMUR; FRACTURES, BONE; HIP; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PLACEBOS; PROSTATIC NEOPLASMS; SPINE; SURVIVAL RATE; TOREMIFENE; UNITED STATES;

EID: 84862782486     PISSN: 00225347     EISSN: 15273792     Source Type: Journal    
DOI: 10.1016/j.juro.2011.10.136     Document Type: Article

References (24)

1. J.F. Maillefert, J. Sibilia, F. Michel Bone mineral density in men treated with synthetic gonadotropin-releasing hormone agonists for prostatic carcinoma J Urol 161 1999 1219
2. A. Berruti, L. Dogliotti, C. Terrone Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy J Urol 167 2002 2361
3. H.W. Daniell, S.R. Dunn, D.W. Ferguson Progressive osteoporosis during androgen deprivation therapy for prostate cancer J Urol 163 2000 181
4. T. Diamond, J. Campbell, C. Bryant The effect of combined androgen blockade on bone turnover and bone mineral densities in men treated for prostate carcinoma: longitudinal evaluation and response to intermittent cyclic etidronate therapy Cancer 83 1998 1561
5. V.B. Shahinian, Y.F. Kuo, J.L. Freeman Risk of fracture after androgen deprivation for prostate cancer N Engl J Med 352 2005 154
6. M.R. Smith, W.C. Lee, J. Brandman Gonadotropin-releasing hormone agonists and fracture risk: a claims-based cohort study of men with nonmetastatic prostate cancer J Clin Oncol 23 2005 7897
7. M.R. Smith, S.P. Boyce, E. Moyneur Risk of clinical fractures after gonadotropin-releasing hormone agonist therapy for prostate cancer J Urol 175 2006 136
8. J.K. Tracy, W.A. Meyer, R.H. Flores Racial differences in rate of decline in bone mass in older men: the Baltimore men's osteoporosis study J Bone Miner Res 20 2005 1228
9. A. George, J.K. Tracy, W.A. Meyer Racial differences in bone mineral density in older men J Bone Miner Res 18 2003 2238
10. D.A. Nelson, G. Jacobsen, D.A. Barondess Ethnic differences in regional bone density, hip axis length, and lifestyle variables among healthy black and white men J Bone Miner Res 10 1995 782
11. M.R. Smith, R.A. Morton, K.G. Barnette Toremifene to reduce fracture risk in men receiving androgen deprivation therapy for prostate cancer J Urol 184 2010 1316
12. H.K. Genant Assessment of vertebral fractures in osteoporosis research J Rheumatol 24 1997 1212
13. SAS Institute Inc. SAS/STAT® 9.1 User's Guide 2004 SAS Institute Inc. Cary, North Carolina
14. H.S. Nam, M.H. Shin, J.M. Zmuda Race/ethnic differences in bone mineral densities in older men Osteoporos Int 21 2010 2115
15. N.H. Bell, L. Gordon, J. Stevens Demonstration that bone mineral density of the lumbar spine, trochanter, and femoral neck is higher in black than in white young men Calcif Tissue Int 56 1995 11
16. N.H. Bell, A.L. Yergey, N.E. Vieira Demonstration of a difference in urinary calcium, not calcium absorption, in black and white adolescents J Bone Miner Res 8 1993 1111
17. N.M. Wright, J. Renault, S. Willi Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral densitya clinical research center study J Clin Endocrinol Metab 80 1995 2291
18. O.M. Gutirrez, W.R. Farwell, D. Kermah Racial differences in the relationship between vitamin D, bone mineral density, and parathyroid hormone in the National Health and Nutrition Examination Survey Osteoporos Int 22 2011 1745
19. J.K. Tracy, W.A. Meyer, M. Grigoryan Racial differences in the prevalence of vertebral fractures in older men: the Baltimore Men's Osteoporosis Study Osteoporos Int 17 2006 99
20. Y. Sheu, J.A. Cauley, V.W. Wheeler Age-related decline in bone density among ethnically diverse older men Osteoporos Int 22 2011 599
21. N.B. Watts, E.M. Lewiecki, P.D. Miller National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist J Clin Densitom 11 2008 473
22. J. Mohler, A.J. Armstrong, R.R. Bahnson et al. National Comprehensive Cancer Network Clinical Practice Guidelines in Oncology Prostate Cancer v.3.2010 http://www.nccn.org/professionals/physician-gls/pdf/prostate.pdf Accessed September 21, 2010
23. P.J. Saylor, N.L. Keating, M.R. Smith Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy J Gen Intern Med 24 2009 S389
24. FRAX®: WHO Fracture Risk Assessment Tool Fracture risk information http://www.shef.ac.uk/FRAX/ Accessed November 18, 2010